Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionAlgert Global Llc
Latest Disclosed Ownership292,929 shares
Latest Disclosed Value $ 1,028
Algert Global Llc reports 32.50% decrease in ownership of IOVA / Iovance Biotherapeutics, Inc.

On May 14, 2026 - Algert Global Llc filed a 13F-HR form disclosing ownership of 292,929 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $1,028,181 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 433,999 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of -32.50% during the quarter. The current value of the position is $1,283,029 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 292,929 -141,070 -32.50 1 0.00 0.0155
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 433,999 433,999 1 0.0185
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -280,882 -100.00 0 0.0000
2025-05-13 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 280,882 224,482 398.02 1 0.0231
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 56,400 2,330 4.31 0 0.0098
2024-11-12 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 54,070 18,784 53.23 1 0.0137
2024-08-15 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 35,286 -3,492 -9.01 0 0.0094
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 38,778 -81,310 -67.71 1 0.0225
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 120,088 -273,688 -69.50 1 -100.00 0.0393
2023-11-13 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 393,776 41,470 11.77 2 -50.00 0.0842
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 352,306 -62,707 -15.11 2 0.00 0.1079
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 415,013 23,620 6.03 3 0.00 0.1197
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 391,393 47,720 13.89 3 -99.94 0.1386
2022-11-15 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 343,673 178,868 108.53 3,292 80.98 0.1989
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 164,805 117,027 244.94 1,819 128.52 0.1368
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 47,778 11,403 31.35 796 14.70 0.0521
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 36,375 2,537 7.50 694 -16.79 0.0867
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 33,838 20,388 151.58 834 138.29 0.1110
2021-08-13 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,450 13,450 350 0.1178
2021-05-14 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -11,621 -100.00 0 -100.00
2021-02-12 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 11,621 11,621 539 0.1537
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -30,757 -100.00 0 -100.00
2020-08-12 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 30,757 -19,392 -38.67 844 -43.77 0.2866
2020-05-13 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 50,149 26,138 108.86 1,501 125.71 0.6328
2020-02-18 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 24,011 24,011 -52.12 665 -55.70 0.1986
2019-11-13 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -13,080 -100.00 0 -100.00
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 13,080 13,080 321 0.1186
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.